glp-1 agonists and sglt2 inhibitors Cardiorenal Protection: Potential of Receptor in the Treatment of Type 2 Diabetes | Diabetes Therapy Benefits of treatment with SGLT2i

Tirzepatide was found to be effective in promoting insulin secretion dependent on glucose through GIPR and GLP1R activation in both in vivo and in vitro models

Naltrexone-bupropion (Contrave) Contrave combines an opioid antagonist (naltrexone) with an antidepressant (bupropion)

Reddys Laboratories, and Glenmarkin India, along with Huadong Medicine, Benemae Pharmaceutical, Hangzhou Jiuyuan Gene Engineering, and Innovent Biologics in China, are actively developing biosimilar and modified GLP-1 analogues targeting both domestic and global markets

The Effect of Semaglutide 2.4 Mg Once Weekly on Energy Intake, Appetite, Control of Eating, and Gastric Emptying in Adults With Obesity

doi: 10.1111/dom.13374

As a GLP-1RA, 102 albiglutide works by stimulating insulin release and reducing glucagon production, leading to improved blood sugar control in patients with T2DM